TCT-150 3D heart models for planning of percutaneous tricuspid interventions  by Taramasso, Maurizio et al.
J O U R N A L O F T H E A M E R I C A N C O L L E G E O F C A R D I O L O G Y , V O L . 6 6 , N O . 1 5 , S U P P L B , 2 0 1 5 B53MODERATED POSTERS: STRUCTURALTuesday, October, 13, 2015, 4:00 PM-6:00 PM
Abstract nos: 150 - 159
TCT-150
3D heart models for planning of percutaneous tricuspid interventions
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BACKGROUND Transcatheter tricuspid valve therapies are an
emerging ﬁeld in structural cardiac interventions. 3D rapid prototyp-
ing of the heart structures can deliver a helpful tool to plan, test and
carry out percutaneous tricuspid procedures.
METHODS Multislice CT Scan (MSCT) was collected from 8 patients
screened while being assessed for potential percutaneous tricuspid
valve intervention. The imaging data were analyzed and manipulated
using dedicated 3D software to create a computer generated 3D mesh
of the right heart and inferior vena cava anatomy. The 3D models were
processed into solid slices by using 3D printing stereo-lithography,
allowing the creation of ﬂexible silicone heart models. Multiplanar
reconstruction of the MSCT was used to measure the following vari-
ables: heart chambers dimension, tricuspid valve diameters and IVC
dimensions. A simulation of the tricuspid device steering capability
within the heart structures has been computed, then replicated in the
real solid printed model. CT dimensional and steering parameters
were compared with the 3D-printed model for consistency. Usability
of the model was assessed evaluating the feedback (ranging from
unsatisfactory to excellent) by two independent operators.
RESULTS Mimicking the patient speciﬁc right heart structures, the
catheter steering angles and the identiﬁcation of the target point were
simulated under multimodality imaging guidance (Fluoroscopic and
Echocardiography). The ability to position the transcatheter device to
the target area was obtained as well as the maneuverability was
evaluated revealing implant feasibility. The steerability of the trans-
catheter device to the target area was successful in all the simulations,
reﬂecting a minimal error (3%) in the angles calculated from the
computational simulation. Usability of the model was assessed as
excellent by operators in all the cases.
CONCLUSIONS 3D printing is helpful clinical tool for planning and
training operators in the early stage of this innovative interventions,
as percutaneous tricuspid procedures. 3D models allowed the
achievement of tangible feedback without the need of extensive
preclinical animal testing, individualizing the procedural planning
and improving the procedural outcomes.CATEGORIES STRUCTURAL: Valvular Disease: Other
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BACKGROUND Frailty is known to correlate with mortality in car-
diovascular diseases. Gait speed, a commonly accepted frailty metric,
has not been well validated in patients undergoing transcatheter
aortic valve replacement (TAVR). Recently, psoas muscle area (PMA),
measured by computed tomography, has been shown to be related to
outcomes in cardiovascular surgery. The purpose of this study was to
determine if PMA can predict mortality as a marker for frailty in pa-
tients following TAVR.
METHODS We retrospectively reviewed 232 consecutive patients un-
dergoing TAVR. Cross-sectional areas of the psoas muscles at the level
of the fourth lumbar vertebra were measured for each patient. PMA
was normalized for height (mm2/m2). The primary endpoint was all-
cause mortality at 90 days and 1 year. The association between PMA
and clinical variables were assessed using multivariate linear regres-
sion model. The association between mortality and clinical variables
including PMA/m2 were assessed using multivariate Cox proportional
hazards model. Gait speed was tested preprocedure in 123 patients,
and was included in subanalysis.
RESULTS Higher PMA/m2 was associated with male gender (r ¼ 0.410,
p <0.001), younger patient (r ¼ 0.234, p <0.001), and better ejection
fraction (r ¼ 0.243, p <0.001). The 90 day and 1 year mortality were
15.9% and 27.1% (mean Society of Thoracic Surgeons score 8.58%).
Importantly, after accounting for multiple risk factors including New
York Heart Association class, prior myocardial infarction, prior stroke,
and estimated glomerular ﬁltration rate, PMA signiﬁcantly correlated
with mortality at 90 days and 1 year mortality (Adjust Hazard Ratio ¼
1.517 [95% CI: 1.19 - 1.93] and 1.245 [95% CI: 1.05 - 1.48], respectively).
When PMA was stratiﬁed into tertiles, Kaplan-Meier analysis
demonstrated the lowest survival probability in patients with the
smallest PMA in both 90 days and 1 year (73.5%, and 60.4%, log-rank
p ¼ 0.010, and 0.048, respectively). In subanalysis, receiver operating
curve showed PMA/m2 in combination with gait speed 0.4 m/s had
the greatest discrimination ability for mortality at both 90 days and 1
year, compared with either PMA/m2 or gait speed alone.
